| Study Period | 2020 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2020 - 2023 |
| CAGR | 4.00% |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
United States Pharmaceutical 3PL Market Analysis by Mordor Intelligence
The United States Pharmaceutical 3PL Market is expected to register a CAGR of greater than 4% during the forecast period.
Due to COVID-19, the pharma supply chain was impacted by distribution challenges created by reduced transportation capacity. Disruptions at ports, quarantined crews, and labor shortages due to lockdowns are all contributing factors. COVID-19 caused the slowdown of the new pharmaceutical product development due to material shortages, disruptions in clinical trials, and backups in FDA approval.
However, the United States is the world's largest market for temperature-sensitive healthcare products such as biopharmaceuticals, vaccines, and clinical trial materials. The rising number of clinical trials employing various temperature-sensitive materials, such as blood samples, tissue samples, and some drugs, have catalyzed the growth of the market. There are many well-established pharmaceutical companies in the United States. The pharmaceutical industry of the United States alone accounts for almost half of the global pharmaceutical market.
Furthermore, the pharmaceutical 3PL industry is bound by strict rules and regulations. For instance, warehouses and shippers of pharmaceuticals in the United States must be registered with the Food and Drug Administration (FDA). There are no exceptions; even if they are planning a short-term or emergency relationship with a 3PL provider, one must make sure they are approved for storing and transporting pharmaceuticals. In addition, government regulations related to the distribution of pharmaceuticals are codified as part of the CGMPs (Current Good Manufacturing Practices), which is the best practice for the health and safety of consumers.
United States Pharmaceutical 3PL Market Trends and Insights
The United States is Leading in the Pharmaceutical Market Across the World
Despite the influence of several growing countries, the United States holds a commanding proportion of the global pharmaceutical market. The country is home to some of the world's largest pharmaceutical corporations, and American customers have access to one of the world's most advanced pharmaceutical systems.
In recent years, pharmaceutical sales revenues in the United States have accounted for about half of the global total. In 2020, the United States had five of the top ten pharmaceutical corporations in the world. AbbVie is the new number one pharmaceutical business in the United States, and its best-selling medicine is Humira. Johnson & Johnson is another American corporation that has made a global impact, with its pharmaceutical division producing a record USD 45.6 billion in 2020. Furthermore, in 2021, the United States was leading in pharmaceutical sales, with more than USD 555 billion, with a growth rate of 7.6% compared to 2020. Also, the country had 46.8% of global sales in 2021 (2020: 46.8%, 2019: 46.5%).
In addition, overall pharmaceutical expenditures in the United States increased by 4.9% in 2020 compared to 2019. This rise was driven by increased utilization (a 2.9% increase) and new medications (a 1.8% increase), with price increases having a little impact (a 0.3% increase).
Understand The Key Trends Shaping This Market
Download PDF
International Trading is Boosting the Market
China has been the leading supplier of medicines in the United States over the last decade, with India and Mexico contending for second and third places, respectively, depending on the year. China, India, and Mexico are the top three pharmaceutical import sources, with Canada, Germany, Italy, the United Kingdom, Israel, Spain, and Ireland filling out the top ten.
In the fiscal year ending March 31, 2021, pharmaceutical exports to India increased by 18.7% to USD 24.44 billion, owing to the increasing demand for the country's generic pharmaceuticals.
Furthermore, in January 2022, export volumes of pharmaceutical goods accounted for more than USD 5.4 billion, with a growth rate of 38% compared to the same month in 2021. Meanwhile, the import volumes slightly declined in 2022 by 6% compared to 2021.
Get Analysis on Important Geographic Markets
Download PDF
Competitive Landscape
The US pharmaceutical 3PL market is competitive and fragmented with the presence of many international players. Although the market is quite fragmented, the efforts of established firms to attain a considerable share in the target market are estimated to build healthy competition among industry players.
Some of the existing major players in the market include Deutsche Post DHL, FedEx, Kuehne + Nagel International AG, United Parcel Service Inc., C.H. Robinson Worldwide Inc., CEVA Logistics, DB Schenker, Agility Logistics, and Expeditors International of Washington Inc. The pharmaceutical industry is expected to witness more acquisitions and mergers as competition increases. This industry is on the right track for continued growth.
United States Pharmaceutical 3PL Industry Leaders
-
DHL
-
UPS
-
FedEx
-
Kuehne + Nagel
-
C. H. Robinson
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Recent Industry Developments
- December 2021: FedEx Corp. began operations at its substantially bigger air cargo hub at Miami International Airport. The USD 72 million addition, two years under development and roughly the size of two football fields, doubles the hub's size to 282,000 square feet. The hub includes FedEx's largest cold storage section, covering 70,000 square feet - the equivalent of 33 tennis courts - of refrigerated and frozen storage.
- May 2021: UPS expanded its specialty pharmaceutical offerings by establishing UPS Cold Chain Solutions, a comprehensive suite of cold chain technologies, best-in-class capabilities, and new and expanded global facilities providing complete, end-to-end temperature-controlled logistics.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now
United States Pharmaceutical 3PL Market Report Scope
Pharmaceutical 3PL refers to the safe and efficient delivery of pharmaceutical drug products to benefit patient health. The US pharmaceutical 3PL market is segmented by function (domestic transportation management, international transportation management, and value-added warehousing and distribution) and supply chain (cold chain and non-cold chain). The report offers the market size and forecasts in value (USD billion) for all the above segments.
Function
| Domestic Transportation Management |
| International Transportation Management |
| Value-added Warehousing and Distribution |
Supply Chain
| Cold Chain |
| Non-cold Chain |
| Function | Domestic Transportation Management |
| International Transportation Management | |
| Value-added Warehousing and Distribution | |
| Supply Chain | Cold Chain |
| Non-cold Chain |
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
What is the current United States Pharmaceutical 3PL Market size?
The United States Pharmaceutical 3PL Market is projected to register a CAGR of greater than 4% during the forecast period (2025-2030)
Who are the key players in United States Pharmaceutical 3PL Market?
DHL, UPS, FedEx, Kuehne + Nagel and C. H. Robinson are the major companies operating in the United States Pharmaceutical 3PL Market.
What years does this United States Pharmaceutical 3PL Market cover?
The report covers the United States Pharmaceutical 3PL Market historical market size for years: 2020, 2021, 2022, 2023 and 2024. The report also forecasts the United States Pharmaceutical 3PL Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
United States Pharmaceutical 3PL Market Report
Statistics for the 2025 United States Pharmaceutical 3PL market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. United States Pharmaceutical 3PL analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
